Online Healthcare Convention

May 18, 2021

 

DATE & TIME

Japanese Company Pitch
July 14-15, 2021
5:00 - 6:30 PM PDT

B2B Meetings
Anytime after the pitch for the company you intend to meet

VENUE
Online (Zoom)

COST
FREE *Registration Required*

REGISTRATION DEADLINE
July 13, 2021 @ 5:00 PM PDT

REGISTRATION FORM
(Keynote & Pitch Session)

Register



CONTACT
JETRO San Francisco
sfc-marketing@jetro.go.jp

OVERVIEW

JETRO invites Japanese corporate venture capital groups (“CVCs”) and new tech/business hunters to make a reverse pitch on the topic of healthcare to potential collaborators. It welcomes as attendees individual companies, venture capitalists, accelerators, incubators, and tech/ business partners from the US and other countries.

The program focuses on Digital Health, Health Devices/Materials, Drug Discovery, and Science Parks, among other topics, and brings together attendees for B2B meetings.

JETRO also invites keynotes speakers who will give attendees insights on how to enter the Japanese market, regulation-related aspects by FDA, and advanced research and development by Japanese and US institutions.

This event is free-of-charge but pre-registration is necessary for both the keynote speech / Japanese company pitch portion and the pre-arranged B2B meetings.


Registration for B2B Meetings: OPEN NOW

Please contact Japanese companies through the "E-mail" shown beside each company's information to request a meeting. You can contact them immediately after registering for the conference. You may schedule your meeting for the prearranged time after the companies' pitch session or for another date or time.


We will record the pitch sessions for those who cannot attend in real time, but you MUST be pre-registered in order to receive a link. The recording will be uploaded day of, so please schedule your B2B meeting for AFTER you intend to watch it. This will help you understand the company's specific goals before meeting 1-on-1.


 AGENDA

DAY 1

 

5:00 - 6:30 PM

Greetings

Maeda Toru, Consul General of Japan in San Francisco

Keynote Speeches

Transpacific Collaboration of Healthcare Business Between Japan and US
Pathways to the U.S. Market for Innovative Medical Devices

Japanese Company Pitches

TOPICS: Digital Health, Device and Materials

6:30 - 8:10 PM

Prearranged B2B Meetings

Participants may apply for a meeting during this time or ask Japanese companies for other dates and times. Contact them through the "E-mail" shown on each company's information.

 

DAY 2

 

5:00 - 6:30 PM

Support for Startups by Japanese Governmental Organizations

Japan External Trade Organization (JETRO)

New Energy and Industrial Technology Development Organization (NEDO)

Keynote Speeches

Toward Bio Digital Twin Creation Based on Causal Mechanisms

SynFini™ - An Automated Chemistry Platform

Japanese Company Pitches

TOPICS: Drug Discovery, Science Park

6:30 - 8:10 PM

Prearranged B2B Meetings

Participants may apply for a meeting during this time or ask Japanese companies for other dates and times. Contact them through the "E-mail" shown on each company's information.


DAY 1

GREETINGS

 

MAEDA Toru
Consul General of Japan in San Francisco


For more details...

KEYNOTES

 

Transpacific Collaboration of Healthcare Business Between Japan and US

Fumiaki Ikeno, MD


Program Director (U.S.) Japan Biodesign

Stanford Biodesign


For more details...


Pathways to the U.S. Market for Innovative Medical Devices

Kenneth J. Cavanaugh Jr., Ph.D.

Deputy Director

Office of Cardiovascular Devices

Center for Devices and Radiological Health

U.S. Food and Drug Administration


For more details...



Moderator


Jack W. Moorman

Chairman, U.S.-Japan MedTech Frontiers

Partner, Nichibei MedTech Advisors, LLC

Principal, LeVaunt, LLC

 

For more details...

JAPANESE COMPANIES'

PITCH SESSIONS


Digital Health





Request B2B meeting:
E-mail

Nippon Life Insurance Company


Nippon Life has collaborated with a number of startups to support their expansion into Japan since entering Silicon Valley in 2016, and in 2020, launched a CVC to start investment activities. The total fund size is $150m, $50m will be invested in strategic VC partners and $100m will be invested in early stage InsureTech, Healthtech and Fintech startups.


In this seminar, we will give an overview of our activities and explain one of our focus areas, the healthcare business in Japan.


For more details...


Request B2B meeting:
E-mail

Dai-ichi Life Holdings, Inc.


As lifestyles continue to diversify, Dai-ichi Life Group will “Protect and improve the well-being of all” to enable a desired lifestyle and way of living for each individual. We believe that in addition to conventional protection, it is essential to provide value that contributes to financial wealth, wellness and enhancing social connections.


For more details...





Request B2B meeting:
E-mail

SOMPO Himawari Life Insurance Inc.

SOMPO Himawari Life aims to be a "Total health support enterprise" and provides new value through "Insurhealth," which combines the essential functions of insurance and healthcare. We provide our customers with innovative insurance products and health services in partnership with companies with superior technologies, helping them to lead healthy lives.


For more details...

Device and Materials




Request B2B meeting:
E-mail

TEIJIN PHARMA LIMITED


Teijin Pharma, is a health care subsidiary of the Japanese Conglomerate, Teijin Group. Teijin Pharma seeks opportunities to introduce non-invasive medical devices/digital solutions into home healthcare in Japan. Historically, Teijin Pharma has had a strong portfolio of technologies and services in the respiratory and sleep areas. We are trying to enhance our existing business and expand into other chronic disease areas, like behavioral-health, lifestyle diseases, rehab, especially if these technologies allow for more effectively treatment at home.


For more details...







Request B2B meeting:
E-mail

Murata Manufacturing Co., Ltd.


“Murata developing advancements in components and solutions for the medical devices of tomorrow.”

Murata is a worldwide leader in the design, manufacture and supply of electronic components and solutions, and is well known for its expertise in advanced materials,, broad product portfolio, global manufacturing capabilities and sales channel. Murata is looking for collaborative partners towards increasing growth in the Healthcare and Medical markets in the US.

Murata’s new technologies, such as stretchable electronics and electrode materials, present opportunities to explore collaborations in numerous application areas.

Murata offers it partners support in various areas, including engineering, product development, customer expansion, channels to market, brand recognition, financial support, and more.


For more details...



Request B2B meeting:
E-mail

Mitsui Chemicals, Inc.


Mitsui Chemicals – keen in robotics, sensing technology and data management

As a petrochemical manufacturer, health care is a high priority for Mitsui Chemicals, Inc. Throughout the event, we hope to get to know with thriving startup companies in the fields of robotics, sensing technology and data management for exciting collaborations. We look forward to exchanging innovative ideas with new partners.

https://jp.mitsuichemicals.com/en/service/next_generation/details.htm

 

For more details...







Request B2B meeting:
E-mail

Toray Industries, Inc.


Toray is one of the world's leading chemical and materials companies, with sales exceeding $22 Billion and over 45,000 employed around the globe in 26 countries.

Along with Toray's core technologies of organic synthetic chemistry, polymer chemistry, and biotechnology, Toray is also a global leader in the development and application of nanotechnology. With these advanced materials technologies, Toray has been able to develop and serve the healthcare and medical markets with many innovative and new products. A few product examples are highly precise wearable ECG garments, breathable PPE, and transparent ABS Resin with superior moldability used in the medical device industry. Toray has launched a best-in-industry polymer optical fiber with the world's highest Numerical Aperture used in endoscopes, etc., as well as a game-changing ultra-fine fiber wiping cloth with superior efficacy against germs and viruses with applications in many settings.


For more details...

DAY 2





Support for Startups by Japanese Governmental Organizations


Japan External Trade Organization (JETRO)

Tak Yamashita
Chief Executive Director, JETRO San Francisco

https://www.jetro.go.jp/en/






New Energy and Industrial Technology Development Organization (NEDO)
Kazuaki Osumi
Director General, NEDO Silicon Valley Office
https://www.nedo.go.jp/english/

KEYNOTES

 



Toward Bio Digital Twin Creation Based on Causal Mechanisms

Joe Alexander, Jr. M.D., Ph.D., F.A.C.C.


Distinguished Scientist
NTT Research, Inc.


For more details...



SynFini™ - An Automated Chemistry Platform

Nathan Collins, Ph.D.


Chief Strategy Officer for Biosciences
SRI International


For more details...

JAPANESE COMPANIES'

PITCH SESSIONS

Drug Discovery



Request B2B meeting:
E-mail

Takeda Pharmaceutical Company Limited


Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company. Neuroscience is a core therapeutic area for Takeda. Our focused diseases are age-related neurological disorders, hereditary neurological disorders, and neuromuscular disorders. We are committed to working in partnership with external experts who share our vision and possess the knowledge and scientific capabilities to make truly transformational medicines for the patients we serve. See Takeda Wishlist (see English at bottom of document).


For more details...






Request B2B meeting:
E-mail: info_lsc@sekisui.com

SEKISUI CHEMICAL CO., LTD


Sekisui Chemical is a world-wide chemical company having broad business portfolio in “Innovative Mobility”, “Advanced Lifeline”, “Residential” and “Life Science” fields, with honorably selected GLOBAL100 (Most Sustainable Corporations in the World) for four sequential years. Our participation of this JETRO event aims at business expansion in the Life Science industry expecting to find new business partners in the US. We will promote our state-of-art mass cell processing materials and technologies.

CORP URL: http://www.sekisuichemical.com
GLOBAL100: https://www.corporateknights.com/reports/2021-global-100/


For more details...





Request B2B meeting:
E-mail

Astellas Innovation Management LLC


Astellas Innovation Management (https://aim.astellas.com/en) plays an important role in identifying, evaluating and accessing early-stage innovations into Astellas through a number of partnerships and alliances with various external partners. Located in key Bio-Hubs in the Bay Area CA, Cambridge MA, Cambridge UK, as well as Tsukuba Japan, AIM has built and developed a strong network across academia and the healthcare sectors. These networks have led to successful partnerships that create win-win situations for Astellas and partners. We look forward to working with you.


For more details...



Request B2B meeting:
E-mail

Taiho Ventures, LLC

Taiho Ventures, LLC is the corporate venture arm of Taiho Pharmaceutical Co., Ltd., a Japanese specialty pharmaceutical company focusing on oncology, allergy and immunology, and urology. With $300M under management, we are actively investing in early-stage private companies strategically relevant to Taiho Pharmaceutical. We consider company creation, spinouts and the option-type of investments as well as pure equity investments.

Website: https://www.taihoventures.com/
Pitch Deck <PDF> (1066KB)


For more details...
Science Park





Request B2B meeting:
E-mail

Shonan Health Innovation Park


Shonan Health Innovation Park (Shonan iPark) is a science park founded in April 2018 by Takeda Pharmaceutical Company. It convenes private and public sector organizations and academic institutions that widely range in terms of business type and scale. More than 2,000 workers from over 100 pharmaceutical, next-generation medicine, AI, venture capital, and government-related companies and organizations together form an ecosystem to accelerate health innovation.

https://www.shonan-health-innovation-park.com/en/


For more details...

PRESENTED BY
Japan External Trade Organization (JETRO) San Francisco

SUPPORTED BY
US-Japan Medtech Frontiers, New Energy and Industrial Technology Development Organization, Japan Society of Northern California, Japanese Chamber of Commerce of Northern California